These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation]. Kovalenko AL; Sosin IK; D'iachenko TV; Chuev IuF; Goncharova EIu; Skalyga IM; Kasparevich AIu; Krivosheeva MD Adv Gerontol; 2014; 27(3):553-9. PubMed ID: 25827006 [TBL] [Abstract][Full Text] [Related]
23. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury]. Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury]. Skoromets AA; Pugacheva EL Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223 [TBL] [Abstract][Full Text] [Related]
25. [Clinical-encephalographic evaluation of preterm children treated with cytoflavin during the first year of life]. Rogatkina SO; Degtiareva MG; Grebennikova OV; Volodin NN; Sigova IuA; Asmolova GA; Serova ND Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):16-23. PubMed ID: 21666588 [TBL] [Abstract][Full Text] [Related]
26. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
27. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma]. Deriugina AV; Shumilova AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087 [TBL] [Abstract][Full Text] [Related]
28. [Efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in 1-month old children with transient neonatal hypothyroidism]. Strukov VI; Maksimova MN; Kuptsova TA; Lysev SF; Shcherbakova YG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):17-20. PubMed ID: 26525615 [TBL] [Abstract][Full Text] [Related]
29. [Perspectives of treatment of patients with ischemic stroke: the place and the role of cytoflavin]. Trofimova SA; Balunov OA; Dubinina EE Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):49-53. PubMed ID: 20559274 [TBL] [Abstract][Full Text] [Related]
30. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316 [TBL] [Abstract][Full Text] [Related]
31. [Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period]. Bagnenko SF; Mirzabaev AT; Batotsyrenov BV; Gorbachev NB; Miroshnichenko VN; Batotsyrenova KhV; Velikiĭ KF Vestn Khir Im I I Grek; 2011; 170(5):14-6, 18. PubMed ID: 22238957 [TBL] [Abstract][Full Text] [Related]
32. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin]. Kartashova EA; Romantsov MG; Sarvilina IV Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853 [TBL] [Abstract][Full Text] [Related]
33. [Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders]. Mazin PV; Sheshunov IV; Mazina NK Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):28-39. PubMed ID: 28399094 [TBL] [Abstract][Full Text] [Related]
34. [SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS]. Parfenov Y; Vasilevskaya M; Parfenov S; Sapozhnikov K; Kovalenko A; Zaplutanov V Georgian Med News; 2018 Oct; (283):89-96. PubMed ID: 30516501 [TBL] [Abstract][Full Text] [Related]
35. [Cytoflavin in the complex treatment of neuroinfections in children]. Skripchenko NV; Egorova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666 [TBL] [Abstract][Full Text] [Related]
36. [Effect of early correction of energy and free-radical homeostasis on the clinical-morphological presentation of cerebral infarction]. Rumiantseva SA; Fedin AI; Bolevich SB; Silina EV; Vasil'ev IuD; Men'shova NI; Iliukhina OA; Goluzova IuN Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):16-21. PubMed ID: 20823824 [TBL] [Abstract][Full Text] [Related]
37. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning]. Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536 [TBL] [Abstract][Full Text] [Related]
38. [Cytoflavin in polychemotherapy of breast cancer]. Kashuro VA; Glushkov SI; Zheregelia SN Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562 [TBL] [Abstract][Full Text] [Related]
39. [The application of combined physiotherapeutic methods for the complex treatment of patients with dyscirculatory encephalopathy]. Shiman AG; Klocheva EG; Kaiumov SF; Shoferova SD; Zhukova MV Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (2):9-12. PubMed ID: 22908466 [TBL] [Abstract][Full Text] [Related]
40. [Cytoflavin in the detoxification of alcohol-dependent patients]. Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]